Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase 2 trial of ixazomib in patients with relapsed multiple myeloma not refractory to bortezomib.
Kumar SK, LaPlant B, Roy V, Reeder CB, Lacy MQ, Gertz MA, Laumann K, Thompson MA, Witzig TE, Buadi FK, Rivera CE, Mikhael JR, Bergsagel PL, Kapoor P, Hwa L, Fonseca R, Stewart AK, Chanan-Khan A, Rajkumar SV, Dispenzieri A. Kumar SK, et al. Among authors: hwa l. Blood Cancer J. 2015 Aug 14;5(8):e338. doi: 10.1038/bcj.2015.60. Blood Cancer J. 2015. PMID: 26275080 Free PMC article. Clinical Trial.
Quantification of circulating clonal plasma cells via multiparametric flow cytometry identifies patients with smoldering multiple myeloma at high risk of progression.
Gonsalves WI, Rajkumar SV, Dispenzieri A, Dingli D, Timm MM, Morice WG, Lacy MQ, Buadi FK, Go RS, Leung N, Kapoor P, Hayman SR, Lust JA, Russell SJ, Zeldenrust SR, Hwa L, Kourelis TV, Kyle RA, Gertz MA, Kumar SK. Gonsalves WI, et al. Among authors: hwa l. Leukemia. 2017 Jan;31(1):130-135. doi: 10.1038/leu.2016.205. Epub 2016 Jul 26. Leukemia. 2017. PMID: 27457702 Free PMC article.
Outcomes of primary refractory multiple myeloma and the impact of novel therapies.
Majithia N, Vincent Rajkumar S, Lacy MQ, Buadi FK, Dispenzieri A, Gertz MA, Hayman SR, Dingli D, Kapoor P, Hwa L, Lust JA, Russell SJ, Go RS, Kyle RA, Kumar SK. Majithia N, et al. Among authors: hwa l. Am J Hematol. 2015 Nov;90(11):981-5. doi: 10.1002/ajh.24131. Epub 2015 Oct 6. Am J Hematol. 2015. PMID: 26214732 Free PMC article.
Overall survival of transplant eligible patients with newly diagnosed multiple myeloma: comparative effectiveness analysis of modern induction regimens on outcome.
Paquin AR, Kumar SK, Buadi FK, Gertz MA, Lacy MQ, Dispenzieri A, Dingli D, Hwa L, Fonder A, Hobbs M, Hayman SR, Zeldenrust SR, Lust JA, Russell SJ, Leung N, Kapoor P, Go RS, Lin Y, Gonsalves WI, Kourelis T, Warsame R, Kyle RA, Rajkumar SV. Paquin AR, et al. Among authors: hwa l. Blood Cancer J. 2018 Dec 11;8(12):125. doi: 10.1038/s41408-018-0163-7. Blood Cancer J. 2018. PMID: 30538223 Free PMC article.
Implications and outcomes of MRD-negative multiple myeloma patients with immunofixation positivity.
Tschautscher M, Jevremovic D, Buadi FK, Lacy MQ, Gertz MA, Dispenzieri A, Kapoor P, Dingli D, Hwa L, Fonder A, Hobbs M, Hayman S, Lust J, Russell S, Leung N, Go R, Lin Y, Gonsalves W, Kourelis T, Warsame R, Kyle RA, Rajkumar V, Kumar S. Tschautscher M, et al. Among authors: hwa l. Am J Hematol. 2020 Mar;95(3):E60-E62. doi: 10.1002/ajh.25702. Epub 2019 Dec 30. Am J Hematol. 2020. PMID: 31840857 Free article. No abstract available.
Characteristics of exceptional responders to autologous stem cell transplantation in multiple myeloma.
Paquin A, Visram A, Kumar SK, Gertz MA, Cantwell H, Buadi FK, Lacy MQ, Dispenzieri A, Dingli D, Hwa L, Fonder A, Hobbs M, Hayman SR, Lust JA, Russell SJ, Leung N, Kapoor P, Go RS, Lin Y, Gonsalves WI, Kourelis T, Warsame R, Kyle RA, Rajkumar SV. Paquin A, et al. Among authors: hwa l. Blood Cancer J. 2020 Aug 28;10(8):87. doi: 10.1038/s41408-020-00353-8. Blood Cancer J. 2020. PMID: 32859899 Free PMC article.
Prognostic impact of posttransplant FDG PET/CT scan in multiple myeloma.
Kaddoura M, Dingli D, Buadi FK, Lacy MQ, Gertz MA, Dispenzieri A, Kapoor P, Hwa L, Fonder A, Hobbs M, Hayman S, Lust J, Leung N, Go RS, Lin Y, Gonsalves W, Kourelis T, Warsame R, Kyle RA, Broski SM, Rajkumar V, Kumar S. Kaddoura M, et al. Among authors: hwa l. Blood Adv. 2021 Jul 13;5(13):2753-2759. doi: 10.1182/bloodadvances.2020004131. Blood Adv. 2021. PMID: 34242392 Free PMC article.
The Effect of Duration of Lenalidomide Maintenance and Outcomes of Different Salvage Regimens in Patients with Multiple Myeloma (MM).
Ho M, Zanwar S, Kapoor P, Gertz M, Lacy M, Dispenzieri A, Hayman S, Dingli D, Baudi F, Muchtar E, Leung N, Kourelis T, Warsame R, Fonder A, Hwa L, Hobbs M, Kyle R, Rajkumar SV, Kumar S. Ho M, et al. Among authors: hwa l. Blood Cancer J. 2021 Sep 22;11(9):158. doi: 10.1038/s41408-021-00548-7. Blood Cancer J. 2021. PMID: 34552051 Free PMC article.
Impact of achieving a complete response to initial therapy of multiple myeloma and predictors of subsequent outcome.
Kaddoura M, Binder M, Dingli D, Buadi FK, Lacy MQ, Gertz MA, Dispenzieri A, Kapoor P, Hwa L, Fonder A, Hobbs M, Hayman S, Leung N, Go RS, Lin Y, Gonsalves W, Kourelis T, Warsame R, Kyle RA, Rajkumar V, Kumar S. Kaddoura M, et al. Among authors: hwa l. Am J Hematol. 2022 Mar 1;97(3):267-273. doi: 10.1002/ajh.26439. Epub 2022 Jan 3. Am J Hematol. 2022. PMID: 34978743 Free article.
52 results